These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28964258)

  • 21. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.
    Wirjanata G; Handayuni I; Prayoga P; Apriyanti D; Chalfein F; Sebayang BF; Kho S; Noviyanti R; Kenangalem E; Campo B; Poespoprodjo JR; Price RN; Marfurt J
    Malar J; 2015 Oct; 14():417. PubMed ID: 26498665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay.
    Druilhe P; Brasseur P; Blanc C; Makler M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2112-6. PubMed ID: 17387158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolution of the Plasmodium vivax multidrug resistance 1 gene in the Greater Mekong Subregion during malaria elimination.
    Ngassa Mbenda HG; Wang M; Guo J; Siddiqui FA; Hu Y; Yang Z; Kittichai V; Sattabongkot J; Cao Y; Jiang L; Cui L
    Parasit Vectors; 2020 Feb; 13(1):67. PubMed ID: 32051017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms.
    Lin JT; Patel JC; Kharabora O; Sattabongkot J; Muth S; Ubalee R; Schuster AL; Rogers WO; Wongsrichanalai C; Juliano JJ
    Am J Trop Med Hyg; 2013 Jun; 88(6):1116-23. PubMed ID: 23509126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
    Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
    Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
    Suwanarusk R; Russell B; Chavchich M; Chalfein F; Kenangalem E; Kosaisavee V; Prasetyorini B; Piera KA; Barends M; Brockman A; Lek-Uthai U; Anstey NM; Tjitra E; Nosten F; Cheng Q; Price RN
    PLoS One; 2007 Oct; 2(10):e1089. PubMed ID: 17971853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivax.
    Schousboe ML; Ranjitkar S; Rajakaruna RS; Amerasinghe PH; Morales F; Pearce R; Ord R; Leslie T; Rowland M; Gadalla NB; Konradsen F; Bygbjerg IC; Roper C; Alifrangis M
    PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004196. PubMed ID: 26539821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
    Chehuan YF; Costa MR; Costa JS; Alecrim MG; Nogueira F; Silveira H; Brasil LW; Melo GC; Monteiro WM; Lacerda MV
    Malar J; 2013 Jul; 12():226. PubMed ID: 23819884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
    Leang R; Barrette A; Bouth DM; Menard D; Abdur R; Duong S; Ringwald P
    Antimicrob Agents Chemother; 2013 Feb; 57(2):818-26. PubMed ID: 23208711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs.
    Fall B; Diawara S; Sow K; Baret E; Diatta B; Fall KB; Mbaye PS; Fall F; Diémé Y; Rogier C; Wade B; Bercion R; Pradines B
    Malar J; 2011 Oct; 10():310. PubMed ID: 22014157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium vivax mdr1 genotypes in isolates from successfully cured patients living in endemic and non-endemic Brazilian areas.
    Gomes LR; Almeida-de-Oliveira NK; de Lavigne AR; de Lima SR; de Pina-Costa A; Brasil P; Daniel-Ribeiro CT; Ménard D; Ferreira-da-Cruz Mde F
    Malar J; 2016 Feb; 15():96. PubMed ID: 26887935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a colorimetric (DELI) test for the evaluation of chemoresistance of Plasmodium falciparum and Plasmodium vivax to commonly used anti-plasmodial drugs in the Brazilian Amazon.
    Pratt-Riccio LR; Chehuan YF; Siqueira MJ; das Graças Alecrim M; Bianco-Junior C; Druilhe P; Brasseur P; de Fátima Ferreira-da-Cruz M; Carvalho LJ; Daniel-Ribeiro CT
    Malar J; 2013 Aug; 12():281. PubMed ID: 23937727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.
    Mint Lekweiry K; Ould Mohamed Salem Boukhary A; Gaillard T; Wurtz N; Bogreau H; Hafid JE; Trape JF; Bouchiba H; Ould Ahmedou Salem MS; Pradines B; Rogier C; Basco LK; Briolant S
    J Antimicrob Chemother; 2012 Feb; 67(2):367-74. PubMed ID: 22086859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms in Pvkelch12 and gene amplification of Pvplasmepsin4 in Plasmodium vivax from Thailand, Lao PDR and Cambodia.
    Duanguppama J; Mathema VB; Tripura R; Day NPJ; Maxay M; Nguon C; von Seidlein L; Dhorda M; Peto TJ; Nosten F; White NJ; Dondorp AM; Imwong M
    Malar J; 2019 Apr; 18(1):114. PubMed ID: 30940150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan.
    Nadeem MF; Khattak AA; Zeeshan N; Zahid H; Awan UA; Yaqoob A; Ashraf NM; Gul S; Alam S; Ahmed W
    Rev Inst Med Trop Sao Paulo; 2021; 63():e59. PubMed ID: 34407160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.